Ok_老虎社区_美港股上老虎

DesmondLQW
2022-01-05

Pfizer to supply U.S. with 10 mln more courses of COVID-19 pills

Jan 4 (Reuters) - The Biden administration doubled its order for Pfizer Inc's oral COVID-19 antivira

Pfizer to supply U.S. with 10 mln more courses of COVID-19 pills

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":695368644,"tweetId":"695368644","gmtCreate":1641345368290,"gmtModify":1641345368290,"author":{"id":3583391280216383,"authorId":3583391280216383,"authorIdStr":"3583391280216383","name":"DesmondLQW","avatar":"https://static.tigerbbs.com/338cb5ec5f0bc424da757383afb6ca1d","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Ok</p></body></html>","htmlText":"<html><head></head><body><p>Ok</p></body></html>","text":"Ok","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/695368644","repostId":1149904182,"repostType":4,"repost":{"id":"1149904182","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641340590,"share":"https://www.laohu8.com/m/news/1149904182?lang=&edition=full","pubTime":"2022-01-05 07:56","market":"us","language":"en","title":"Pfizer to supply U.S. with 10 mln more courses of COVID-19 pills","url":"https://stock-news.laohu8.com/highlight/detail?id=1149904182","media":"Reuters","summary":"Jan 4 (Reuters) - The Biden administration doubled its order for Pfizer Inc's oral COVID-19 antivira","content":"<html><head></head><body><p>Jan 4 (Reuters) - The Biden administration doubled its order for Pfizer Inc&#39;s oral COVID-19 antiviral treatment, the company and the White House said on Tuesday, providing the government a total of 20 million courses as it fights a record surge in COVID-19 cases.</p><p>The White House now expects some 4 million treatment courses of the pills to be available by the end of January and 10 million by June, three months sooner than previously planned, according to an administration official.</p><p>&#34;We&#39;re getting them as soon as they come off the line,&#34; the official said.</p><p>Details of the expanded deal, Pfizer&#39;s largest yet for the pill, were not disclosed by the company.</p><p>For the first order of 10 million courses in November, the U.S. government had said it would pay Pfizer $5.29 billion.</p><p>&#34;These pills will be delivered in the coming months and have been shown to dramatically decrease hospitalization and death from COVID-19,&#34; the White House said on Twitter.</p><p>Pfizer&#39;s two-drug regimen called Paxlovid, which is meant to be taken at home for five days soon after onset of COVID symptoms, was authorized last month for people aged 12 and older. In a clinical trial, it was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness.</p><p>The U.S. official said Washington could activate the Defense Production Act or use other extraordinary powers to speed deliveries if Pfizer encounters any production difficulties.</p><p>A rival antiviral pill from Merck &amp; Co also won regulatory authorization last month. The U.S. government has a deal for as many as 5 million courses of the pill, molnupiravir, at a price of $700 per course.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer to supply U.S. with 10 mln more courses of COVID-19 pills</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer to supply U.S. with 10 mln more courses of COVID-19 pills\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-05 07:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Jan 4 (Reuters) - The Biden administration doubled its order for Pfizer Inc&#39;s oral COVID-19 antiviral treatment, the company and the White House said on Tuesday, providing the government a total of 20 million courses as it fights a record surge in COVID-19 cases.</p><p>The White House now expects some 4 million treatment courses of the pills to be available by the end of January and 10 million by June, three months sooner than previously planned, according to an administration official.</p><p>&#34;We&#39;re getting them as soon as they come off the line,&#34; the official said.</p><p>Details of the expanded deal, Pfizer&#39;s largest yet for the pill, were not disclosed by the company.</p><p>For the first order of 10 million courses in November, the U.S. government had said it would pay Pfizer $5.29 billion.</p><p>&#34;These pills will be delivered in the coming months and have been shown to dramatically decrease hospitalization and death from COVID-19,&#34; the White House said on Twitter.</p><p>Pfizer&#39;s two-drug regimen called Paxlovid, which is meant to be taken at home for five days soon after onset of COVID symptoms, was authorized last month for people aged 12 and older. In a clinical trial, it was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness.</p><p>The U.S. official said Washington could activate the Defense Production Act or use other extraordinary powers to speed deliveries if Pfizer encounters any production difficulties.</p><p>A rival antiviral pill from Merck &amp; Co also won regulatory authorization last month. The U.S. government has a deal for as many as 5 million courses of the pill, molnupiravir, at a price of $700 per course.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149904182","content_text":"Jan 4 (Reuters) - The Biden administration doubled its order for Pfizer Inc's oral COVID-19 antiviral treatment, the company and the White House said on Tuesday, providing the government a total of 20 million courses as it fights a record surge in COVID-19 cases.The White House now expects some 4 million treatment courses of the pills to be available by the end of January and 10 million by June, three months sooner than previously planned, according to an administration official.\"We're getting them as soon as they come off the line,\" the official said.Details of the expanded deal, Pfizer's largest yet for the pill, were not disclosed by the company.For the first order of 10 million courses in November, the U.S. government had said it would pay Pfizer $5.29 billion.\"These pills will be delivered in the coming months and have been shown to dramatically decrease hospitalization and death from COVID-19,\" the White House said on Twitter.Pfizer's two-drug regimen called Paxlovid, which is meant to be taken at home for five days soon after onset of COVID symptoms, was authorized last month for people aged 12 and older. In a clinical trial, it was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness.The U.S. official said Washington could activate the Defense Production Act or use other extraordinary powers to speed deliveries if Pfizer encounters any production difficulties.A rival antiviral pill from Merck & Co also won regulatory authorization last month. The U.S. government has a deal for as many as 5 million courses of the pill, molnupiravir, at a price of $700 per course.","news_type":1},"isVote":1,"tweetType":1,"viewCount":308,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Pfizer to supply U.S. with 10 mln more courses of COVID-19 pills

评论（1）

热议股票